Active, Not Recruiting
RECLAIM STUDY: A Phase 2 Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol Use Disorder (AUD) in Subjects With Obesity or Overweight
NCT06987513
- Conditions
- Alcohol Use Disorder (AUD), Alcohol-Related Disorders, Alcoholism, +11 more
- Locations
-
- Altimmune Clinical Study Site Los Angeles, California, United States
- Altimmune Clinical Study Site Aurora, Colorado, United States
- Altimmune Clinical Study Site New Haven, Connecticut, United States
- Altimmune Clinical Study Site Fort Myers, Florida, United States